Although most correlations were not statistically significant, this is consistent with previous studies32, suggesting that AD pathology is driven by diverse pathological conditions, such as Aβ pathology, tau pathology, and axonal degeneration, each eliciting different biomarker responses. The gene discussed is MAPT; the disease is Alzheimer disease.